Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 21 July

Jessica Amir
July 21, 2020

Morning Bell 20 July

Jessica Amir
July 20, 2020

Weekly Wrap 17 July

Bell Direct
July 17, 2020

Morning Bell 17 July

Jessica Amir
July 17, 2020

Morning Bell 16 July

Jessica Amir
July 16, 2020

Morning Bell 15 July

Jessica Amir
July 15, 2020

Morning Bell 14 July

Jessica Amir
July 14, 2020

Morning Bell 13 July

Jessica Amir
July 13, 2020

Weekly Wrap 10 July

Jessica Amir
July 10, 2020

Morning Bell 10 July

Jessica Amir
July 10, 2020

Morning Bell 9 July

Jessica Amir
July 9, 2020